263 related articles for article (PubMed ID: 27512969)
1. Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
Kim GR; Cho SN; Kim HS; Yu SY; Choi SY; Ryu Y; Lin MQ; Jin L; Kee HJ; Jeong MH
J Hypertens; 2016 Nov; 34(11):2206-19. PubMed ID: 27512969
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
[TBL] [Abstract][Full Text] [Related]
3. HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.
Bai L; Kee HJ; Choi SY; Seok YM; Kim GR; Kee SJ; Kook H; Jeong MH
Biomed Pharmacother; 2021 Feb; 134():111162. PubMed ID: 33360932
[TBL] [Abstract][Full Text] [Related]
4. MC1568 Inhibits Thimerosal-Induced Apoptotic Cell Death by Preventing HDAC4 Up-Regulation in Neuronal Cells and in Rat Prefrontal Cortex.
Guida N; Laudati G; Mascolo L; Cuomo O; Anzilotti S; Sirabella R; Santopaolo M; Galgani M; Montuori P; Di Renzo G; Canzoniero LM; Formisano L
Toxicol Sci; 2016 Dec; 154(2):227-240. PubMed ID: 27660204
[TBL] [Abstract][Full Text] [Related]
5. Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.
Prasad AM; Morgan DA; Nuno DW; Ketsawatsomkron P; Bair TB; Venema AN; Dibbern ME; Kutschke WJ; Weiss RM; Lamping KG; Chapleau MW; Sigmund CD; Rahmouni K; Grumbach IM
J Am Heart Assoc; 2015 Jun; 4(6):e001949. PubMed ID: 26077587
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 4 controls neointimal hyperplasia via stimulating proliferation and migration of vascular smooth muscle cells.
Usui T; Morita T; Okada M; Yamawaki H
Hypertension; 2014 Feb; 63(2):397-403. PubMed ID: 24166750
[TBL] [Abstract][Full Text] [Related]
7. Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy.
Li H; Li W; Gupta AK; Mohler PJ; Anderson ME; Grumbach IM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H688-98. PubMed ID: 20023119
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.
Xiong C; Guan Y; Zhou X; Liu L; Zhuang MA; Zhang W; Zhang Y; Masucci MV; Bayliss G; Zhao TC; Zhuang S
FASEB J; 2019 Jul; 33(7):8249-8262. PubMed ID: 30951378
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension.
Choi SY; Kee HJ; Sun S; Seok YM; Ryu Y; Kim GR; Kee SJ; Pflieger M; Kurz T; Kassack MU; Jeong MH
J Cell Mol Med; 2019 Apr; 23(4):2801-2812. PubMed ID: 30734467
[TBL] [Abstract][Full Text] [Related]
10. CaM kinase IIdeltaC phosphorylation of 14-3-3beta in vascular smooth muscle cells: activation of class II HDAC repression.
Ellis JJ; Valencia TG; Zeng H; Roberts LD; Deaton RA; Grant SR
Mol Cell Biochem; 2003 Jan; 242(1-2):153-61. PubMed ID: 12619878
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4.
Backs J; Backs T; Bezprozvannaya S; McKinsey TA; Olson EN
Mol Cell Biol; 2008 May; 28(10):3437-45. PubMed ID: 18332106
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase D1 mediates class IIa histone deacetylase phosphorylation and nuclear extrusion in intestinal epithelial cells: role in mitogenic signaling.
Sinnett-Smith J; Ni Y; Wang J; Ming M; Young SH; Rozengurt E
Am J Physiol Cell Physiol; 2014 May; 306(10):C961-71. PubMed ID: 24647541
[TBL] [Abstract][Full Text] [Related]
13. Cellular Repressor of E1A-Stimulated Genes Is a Critical Determinant of Vascular Remodeling in Response to Angiotensin II.
Li Y; Liu Y; Tian X; Zhang Y; Song H; Liu M; Zhang X; Liu H; Zhang J; Zhang Q; Liu D; Peng C; Yan C; Han Y
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):485-494. PubMed ID: 28062494
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.
Findeisen HM; Gizard F; Zhao Y; Qing H; Heywood EB; Jones KL; Cohn D; Bruemmer D
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):851-60. PubMed ID: 21233448
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
16. Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension.
Ryu Y; Kee HJ; Sun S; Seok YM; Choi SY; Kim GR; Kee SJ; Pflieger M; Kurz T; Kim HS; Jeong MH
PLoS One; 2019; 14(3):e0213186. PubMed ID: 30830950
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy.
Xu X; Ha CH; Wong C; Wang W; Hausser A; Pfizenmaier K; Olson EN; McKinsey TA; Jin ZG
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2355-62. PubMed ID: 17823368
[TBL] [Abstract][Full Text] [Related]
18. Nuclear calcium/calmodulin-dependent protein kinase IIdelta preferentially transmits signals to histone deacetylase 4 in cardiac cells.
Little GH; Bai Y; Williams T; Poizat C
J Biol Chem; 2007 Mar; 282(10):7219-31. PubMed ID: 17179159
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha enhances neutrophil adhesiveness: induction of vascular cell adhesion molecule-1 via activation of Akt and CaM kinase II and modifications of histone acetyltransferase and histone deacetylase 4 in human tracheal smooth muscle cells.
Lee CW; Lin CC; Luo SF; Lee HC; Lee IT; Aird WC; Hwang TL; Yang CM
Mol Pharmacol; 2008 May; 73(5):1454-64. PubMed ID: 18227124
[TBL] [Abstract][Full Text] [Related]
20. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
Yang C; Wu X; Shen Y; Liu C; Kong X; Li P
Eur J Pharmacol; 2020 Sep; 883():173384. PubMed ID: 32707188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
